Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
A von Eckardstein, … , A Benninghoven, G Assmann
A von Eckardstein, … , A Benninghoven, G Assmann
Published December 1, 1989
Citation Information: J Clin Invest. 1989;84(6):1722-1730. https://doi.org/10.1172/JCI114355.
View: Text | PDF
Research Article

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

  • Text
  • PDF
Abstract

Six unrelated families with genetically determined structural variants of apo A-I were found in the course of an electrophoretic screening program for apo A-I variants in dried blood samples of newborns. The following structural variations were identified by the combined use of HPLC, time-of-flight secondary ion mass spectrometry (TOF-SIMS), and automated gas phase sequencing: Pro3----Arg (1x), Pro4----Arg (1x), and Pro165----Arg (4x). All variant carriers were heterozygous for their mutant of apo A-I. Subjects heterozygous for apo A-I(Pro165----Arg) (n = 12) were found to exhibit lower mean values for apo A-I (109 +/- 16 mg/dl) and HDL cholesterol (37 +/- 9 mg/dl) than unaffected family members (n = 9): 176 +/- 41 and 64 +/- 18 mg/dl, respectively (P less than 0.001). In 9 of 12 apo A-I(Pro165----Arg) variant carriers the concentrations of apo A-I were below the fifth percentile of sex-matched controls. By two-dimensional immunoelectrophoresis as well as by densitometry the relative concentration of the variant apo A-I in heterozygous carriers of apo A-I(Pro165----Arg) was determined to account for only 30% of the total plasma apo A-I mass instead of the expected 50%. Thus, the observed apo A-I deficiency may be largely a consequence of the decreased concentration of the variant apo A-I. In the case of the apo A-I(Pro3----Arg) mutant, densitometry of HDL apolipoproteins demonstrated a distinctly increased concentration of the variant proapo A-I relative to normal proapo A-I. This phenomenon was not observed in the apo A-I(Pro4----Arg) mutant or in other mutants. This suggests that the interspecies conserved proline residue in position 3 of mature apo A-I is functionally important for the regular enzymatic conversion of proapo A-I to mature apo A-I.

Authors

A von Eckardstein, H Funke, A Henke, K Altland, A Benninghoven, G Assmann

×

Total citations by year

Year: 2021 2019 2016 2015 2014 2013 2012 2010 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 Total
Citations: 1 1 1 2 1 1 3 5 1 1 2 4 4 1 7 4 7 7 6 6 7 5 77
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (77)

Title and authors Publication Year
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
MP Adorni, N Ronda, F Bernini, F Zimetti
Cells 2021
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
A Chroni, D Kardassis
Current medicinal chemistry 2019
Structural Insights into High Density Lipoprotein: Old Models and New Facts
V Gogonea
Frontiers in pharmacology 2016
Reducing protein oxidation in low-flow electrospray enables deeper investigation of proteoforms by top down proteomics
K Kim, PD Compton, TK Toby, PM Thomas, JT Wilkins, RK Mutharasan, NL Kelleher
EuPA Open Proteomics 2015
Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased LCAT activation and cellular cholesterol efflux
P Anthanont, BF Asztalos, E Polisecki, B Zachariah, EJ Schaefer
Journal of Clinical Lipidology 2015
Mining the genome for lipid genes
JA Kuivenhoven, RA Hegele
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014
Mutation mapping of apolipoprotein A-I structure assisted with the putative cholesterol recognition regions
AD Dergunov
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2013
Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach
CL Haase, R Frikke-Schmidt, BG Nordestgaard, A Tybjærg-Hansen
PLoS genetics 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach
CL Haase, R Frikke-Schmidt, BG Nordestgaard, A Tybjærg-Hansen, MI McCarthy
PLoS genetics 2012
Apolipoprotein Mimetic Peptides: Mechanisms of Action as Anti-atherogenic Agents
DO Osei-Hwedieh, M Amar, D Sviridov, AT Remaley
Pharmacology & Therapeutics 2010
The HDL Handbook
NJ Hime
The HDL Handbook 2010
High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
EJ Schaefer
2010
Handbook of Genomics and the Family
KP Tercyak
2010
Analysis of Opioid and Amyloid Peptides Using Time-of-Flight Secondary Ion Mass Spectrometry
S Solé-Domènech, B Johansson, M Schalling, J Malm, P Sjövall
Analytical Chemistry 2010
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency
L Pisciotta, R Miccoli, A Cantafora, L Calabresi, P Tarugi, P Alessandrini, GB Bon, G Franceschini, C Cortese, S Calandra, S Bertolini
Atherosclerosis 2003
The Effects of Altered Apolipoprotein A-I Structure on Plasma HDL Concentration
MG Sorci-Thomas, MJ Thomas
Trends in Cardiovascular Medicine 2002
Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-IZaragoza (L144R)
D Recalde, W Velez-Carrasco, F Civeira, A Cenarro, D Gomez-Coronado, JM Ordovas, M Pocovi
Atherosclerosis 2001
Characterization of the Maturation of Human Pro-apolipoprotein A-I in an in Vitro Model
LE Pyle, D Sviridov, NH Fidge
Biochemistry 2001
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow
Annual Review of Genetics 2000
Evidence of Linkage of Familial Hypoalphalipoproteinemia to a Novel Locus on Chromosome 11q23
EN Kort, DG Ballinger, W Ding, SC Hunt, BR Bowen, V Abkevich, K Bulka, B Campbell, C Capener, A Gutin, K Harshman, M McDermott, T Thorne, H Wang, B Wardell, J Wong, PN Hopkins, M Skolnick, M Samuels
The American Journal of Human Genetics 2000
Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Δ6 and Wild-type ApoA-I in Transgenic Mice
MG Sorci-Thomas, M Thomas, L Curtiss, M Landrum
The Journal of biological chemistry 2000
Apolipoprotein A-I: structure–function relationships
PG Frank, YL Marcel
Journal of lipid research 2000
In vivo kinetics of human apolipoprotein A-I variants in rabbits
Saku, von Eckardstein, Zhang, Liu, Jimi, Ou, Ohta, Assmann, Arakawa
European Journal of Clinical Investigation 1999
Fast C18 solid-phase desalting/delipidation of the human serum apolipoproteins for matrix-assisted laser desorption ionization and electrospray ionization mass spectrometric analysis
LK Watkins, PV Bondarenko, DC Barbacci, S Song, SL Cockrill, DH Russell, RD Macfarlane
Journal of Chromatography A 1999
A Novel Mutant, ApoA-I Nichinan (Glu235→0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells
H Han, J Sasaki, A Matsunaga, H Hakamata, W Huang, M Ageta, T Taguchi, T Koga, M Kugi, S Horiuchi, K Arakawa
Arteriosclerosis, thrombosis, and vascular biology 1999
Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
U Daum, TP Leren, C Langer, A Chirazi, P Cullen, PH Pritchard, G Assmann, A von Eckardstein
Journal of lipid research 1999
Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107→0)
M Tilly-Kiesi, AH Lichtenstein, J Rintarahko, MR Taskinen
Atherosclerosis 1998
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107→0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency
M Tilly-Kiesi, CJ Packard, J Kahri, C Ehnholm, J Shepherd, MR Taskinen
Atherosclerosis 1997
The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano
E Bruckert, A Eckardstein, H Funke, I Beucler, H Wiebusch, G Turpin, G Assmann
Atherosclerosis 1997
The Carboxyl-terminal Hydrophobic Residues of Apolipoprotein A-I Affect Its Rate of Phospholipid Binding and Its Association with High Density Lipoprotein
M Laccotripe, SC Makrides, A Jonas, VI Zannis
The Journal of biological chemistry 1997
Apolipoprotein A-I Fin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene
HE Miettinen, H Gylling, TA Miettinen, J Viikari, L Paulin, K Kontula
Arteriosclerosis, thrombosis, and vascular biology 1997
Subjects With ApoA-I(Lys 107 →0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII)
M Tilly-Kiesi, AH Lichtenstein, JM Ordovas, G Dolnikowski, R Malmström, MR Taskinen, EJ Schaefer
Arteriosclerosis, thrombosis, and vascular biology 1997
Apolipoprotein A-I FIN (Leu159→Arg) Mutation Affects Lecithin: Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts
HE Miettinen, M Jauhiainen, H Gylling, S Ehnholm, A Palomäki, TA Miettinen, K Kontula
Arteriosclerosis, thrombosis, and vascular biology 1997
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
TP Leren, KS Bakken, U Daum, L Ose, K Berg, G Assmann, A von Eckardstein
Journal of lipid research 1997
Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100 → His) and A-I Kurume (His 162 → Gin)
K Moriyama, J Sasaki, A Matsunaga, Y Takada, M Kagimoto, K Arakawa
Clinical Genetics 1996
Identification of Two Apolipoprotein Variants, A-I Kaho (Asp 51^|^rarr;Val) and A-I Lys 107 Deletion
K Moriyama, J Sasaki, A Matsunaga, K Arakawa
Journal of Atherosclerosis and Thrombosis 1996
Important Aspects concerning the Quantification of Biomolecules by Time-of-Flight Secondary-Ion Mass Spectrometry
DC Muddiman, AJ Nicola, A Proctor, DM Hercules
Applied Spectroscopy 1996
Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R) Pisa , and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease
R Miccoli, A Bertolotto, R Navalesi, L Odoguardi, A Boni, J Wessling, H Funke, H Wiebusch, A von Eckardstein, G Assmann
Circulation 1996
Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides
RM Epand, Y Shai, JP Segrest, GM Anantharamiah
Biopolymers 1995
Structural models of human apolipoprotein A-I
C Brouillette
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1995
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis
R Navalesi, R Miccoli, L Odoguardi, H Funke, A Eckardstein, H Wiebusch, G Assmann
The Lancet 1995
The genetic determinants of plasma cholesterol and response to diet
SE Humphries, RE Peacock, PJ Talmud
Baillière's Clinical Endocrinology and Metabolism 1995
Signal sorting by G-protein-linked receptors
G Milligan
Advances in pharmacology (San Diego, Calif.) 1995
Screening for naturally occurring apolipoprotein A-I variants: apo A-I(?K107) is associated with low HDL-cholesterol levels in men but not in women
JR Nofer, A Eckardstein, H Wiebusch, W Weng, H Funke, H Schulte, E Khler, G Assmann
Human Genetics 1995
ApoA-I Helsinki (Lys 107 →0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency
M Tilly-Kiesi, Z Qiuping, S Ehnholm, J Kahri, S Lahdenperä, C Ehnholm, MR Taskinen
Arteriosclerosis, thrombosis, and vascular biology 1995
Homozygous Tangier disease and cardiovascular disease
C Serfaty-Lacrosniere, F Civeira, A Lanzberg, P Isaia, J Berg, ED Janus, MP Smith, PH Pritchard, J Frohlich, RS Lees, GF Barnard, JM Ordovas, EJ Schaefer
Atherosclerosis 1994
Vascular Endothelium
MA Gimbrone, MI Cybulsky, N Kume, T Collins, N Resnick
Annals of the New York Academy of Sciences 1994
A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells
Y Huang, A Eckardstein, S Wu, N Maeda, G Assmann
Proceedings of the National Academy of Sciences 1994
Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum
RS McLeod, C Robbins, A Burns, Z Yao, PH Pritchard
Biochemical Journal 1994
Characterization of two new human apolipoprotein A-I variants: Apolipoprotein A-I Tsushima (Trp-108 → Arg) and A-I Hita (Ala-95→ Asp)
A Keiichi, S Jun, M Akira, T Yoichi, M Kengo, H Kazuko, A Kikuo
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1994
Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens
SA Schreyer, LK Hart, AD Attie
Arteriosclerosis Thrombosis and Vascular Biology 1994
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardiovascular disease
SE Humphries
Clinica Chimica Acta 1993
In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits
K Saku, R Liu, K Ohkubo, H Bai, K Hirata, K Yamamoto, Y Morimoto, K Yamada, K Arakawa
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1993
Structural and functional properties of natural and chemical variants of apolipoprotein A-I
A Jonas, AV Eckardstein, L Churgay, WW Mantulin, G Assmann
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1993
Advances in Human Genetics 21
H Harris, K Hirschhorn
1993
Human Apolipoprotein Mutants III
CR Sirtori, G Franceschini, BH Brewer
1993
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165–>Arg)
A von Eckardstein, G Castro, I Wybranska, N Theret, P Duchateau, N Duverger, JC Fruchart, G Ailhaud, G Assmann
The Journal of biological chemistry 1993
Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations
H Paul-Hayase, M Rosseneu, D Robinson, JP Bervliet, JP Deslypere, SE Humphries
Human Genetics 1992
Cellular and Molecular Biology of Atherosclerosis
AM Gotto
1992
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis
DJ Rader, RE Gregg, Meng, , LA Zech, Benson, HB Brewer
Journal of lipid research 1992
Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei
JS Owen, MP Gillett, TE Hughes
Journal of lipid research 1992
Apolipoprotein genes and atherosclerosis
JL Breslow
The Clinical Investigator 1992
Analysis of familial hypoalphalipoproteinemia syndromes
J Frohlich, PH Pritchard
Molecular and Cellular Biochemistry 1992
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities
H Funke, A Eckardstein, PH Pritchard, M Karas, JJ Albers, G Assmann
Journal of Clinical Investigation 1991
Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia
A Eckardstein, H Holz, M Sandkamp, W Weng, H Funke, G Assmann
Journal of Clinical Investigation 1991
HDL and atherosclerosis: An update
JT Gwynne
Clinical Cardiology 1991
DNA Polymorphisms as Disease Markers
DJ Galton, G Assmann
1991
Characterization of a new human apolipoprotein A-I Yame by direct sequencing of polymerase chain reaction-amplified DNA
Y Takada, J Sasaki, M Seki, S Ogata, Y Teranishi, K Arakawa
Journal of lipid research 1991
Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants
A Jonas, A von Eckardstein, KE Kézdy, A Steinmetz, G Assmann
Journal of lipid research 1991
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III
A von Eckardstein, M Walter, H Holz, A Benninghoven, G Assmann
Journal of lipid research 1991
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
WC Nichols, RE Gregg, HB Brewer, MD Benson
Genomics 1990
Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia, in Vivo Kinetics
CL Malmendier, P Alaupovic, HB Brewer
1990
Advances in Human Genetics
H Harris, K Hirschhorn
1990
Spontaneous high density lipoprotein deficiency syndrome associated with a Z-linked mutation in chickens
F Poernama, SA Schreyer, JJ Bitgood, ME Cook, AD Attie
Journal of lipid research 1990
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure
A von Eckardstein, H Funke, M Walter, K Altland, A Benninghoven, G Assmann
The Journal of biological chemistry 1990

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts